肿瘤免疫治疗的新时代 - Suppr

Suppr

超能文献

[New era of tumor immunotherapy].

作者信息

Yoshitake Yoshihiro, Nakatsura Tetsuya, Nishimura Yasuharu

机构信息

Department of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University.

出版信息

Nihon Rinsho. 2005 Apr;63 Suppl 4:46-55.

PMID:15861634

Abstract

摘要

相似文献

[New era of tumor immunotherapy].

Nihon Rinsho. 2005 Apr;63 Suppl 4:46-55.

Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes.

Vaccine. 2009 May 26;27(25-26):3405-15. doi: 10.1016/j.vaccine.2009.01.074. Epub 2009 Feb 5.

Tumor immunology top 10 list.

Immunol Rev. 2008 Apr;222:5-8. doi: 10.1111/j.1600-065X.2008.00623.x.

[Antitumor immunity and cellular cancer therapies].

Med Sci (Paris). 2003 Jan;19(1):43-53. doi: 10.1051/medsci/200319143.

Cytotoxic T lymphocytes: the future of cancer stem cell eradication?

Immunotherapy. 2013 Jun;5(6):549-51. doi: 10.2217/imt.13.44.

[Cancer immunotherapy].

Duodecim. 1999;115(7):785-94.

T-cell epitope peptide vaccines.

Expert Rev Vaccines. 2004 Oct;3(5):563-75. doi: 10.1586/14760584.3.5.563.

Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.

J Immunol. 1992 Jan 1;148(1):285-91.

[Peptide-based vaccine therapy for cancer patients].

Nihon Rinsho. 2005 Apr;63 Suppl 4:602-7.

Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

Expert Opin Biol Ther. 2010 Nov;10(11):1539-53. doi: 10.1517/14712598.2010.526105.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[New era of tumor immunotherapy].

Nihon Rinsho. 2005 Apr;63 Suppl 4:46-55.

Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes.

Vaccine. 2009 May 26;27(25-26):3405-15. doi: 10.1016/j.vaccine.2009.01.074. Epub 2009 Feb 5.

Tumor immunology top 10 list.

Immunol Rev. 2008 Apr;222:5-8. doi: 10.1111/j.1600-065X.2008.00623.x.

[Antitumor immunity and cellular cancer therapies].

Med Sci (Paris). 2003 Jan;19(1):43-53. doi: 10.1051/medsci/200319143.

Cytotoxic T lymphocytes: the future of cancer stem cell eradication?

Immunotherapy. 2013 Jun;5(6):549-51. doi: 10.2217/imt.13.44.

[Cancer immunotherapy].

Duodecim. 1999;115(7):785-94.

T-cell epitope peptide vaccines.

Expert Rev Vaccines. 2004 Oct;3(5):563-75. doi: 10.1586/14760584.3.5.563.

Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.

J Immunol. 1992 Jan 1;148(1):285-91.

[Peptide-based vaccine therapy for cancer patients].

Nihon Rinsho. 2005 Apr;63 Suppl 4:602-7.

Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

Expert Opin Biol Ther. 2010 Nov;10(11):1539-53. doi: 10.1517/14712598.2010.526105.